Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-25 @ 1:37 PM
NCT ID: NCT00675792
Description: None
Frequency Threshold: 5
Time Frame: Up to 7 days after administration of IMP
Study: NCT00675792
Study Brief: Comparison of Sugammadex Administered at 1-2 Post Tetanic Counts (PTCs) or Better With Neostigmine Administered as Per Standard of Care to Reverse Rocuronium-Induced Neuromuscular Blockade in Adults Undergoing Elective Open Abdominal Procedure (19.4.334) (P05774)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Sugammadex 4 mg/kg sugammadex None None 4 51 51 51 View
Neostigmine 50 µg/kg neostigmine None None 6 49 49 49 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Postoperative wound complication None Injury, poisoning and procedural complications MedDRA 11.1 View
Atrial fibrillation None Cardiac disorders MedDRA 11.1 View
Constipation None Gastrointestinal disorders MedDRA 11.1 View
Small intestinal obstruction None Gastrointestinal disorders MedDRA 11.1 View
Pelvic abscess None Infections and infestations MedDRA 11.1 View
Wound infection staphylococcal None Infections and infestations MedDRA 11.1 View
Postoperative ileus None Injury, poisoning and procedural complications MedDRA 11.1 View
Fluid overload None Metabolism and nutrition disorders MedDRA 11.1 View
Acute respiratory failure None Respiratory, thoracic and mediastinal disorders MedDRA 11.1 View
Bronchial secretion retention None Respiratory, thoracic and mediastinal disorders MedDRA 11.1 View
Hypoxia None Respiratory, thoracic and mediastinal disorders MedDRA 11.1 View
Anastomotic leak None Injury, poisoning and procedural complications MedDRA 11.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal distension None Gastrointestinal disorders MedDRA 11.1 View
Constipation None Gastrointestinal disorders MedDRA 11.1 View
Flatulence None Gastrointestinal disorders MedDRA 11.1 View
Vomiting None Gastrointestinal disorders MedDRA 11.1 View
Pyrexia None General disorders MedDRA 11.1 View
Incision site pain None Injury, poisoning and procedural complications MedDRA 11.1 View
Procedural nausea None Injury, poisoning and procedural complications MedDRA 11.1 View
Procedural pain None Injury, poisoning and procedural complications MedDRA 11.1 View
Dizziness None Nervous system disorders MedDRA 11.1 View
Headache None Nervous system disorders MedDRA 11.1 View
Insomnia None Psychiatric disorders MedDRA 11.1 View
Hiccups None Respiratory, thoracic and mediastinal disorders MedDRA 11.1 View
Oropharyngeal pain None Respiratory, thoracic and mediastinal disorders MedDRA 11.1 View
Pruritus None Skin and subcutaneous tissue disorders MedDRA 11.1 View
Ileus None Gastrointestinal disorders MedDRA 11.1 View
Nausea None Gastrointestinal disorders MedDRA 11.1 View
Procedural hypertension None Injury, poisoning and procedural complications MedDRA 11.1 View
Bladder spasm None Renal and urinary disorders MedDRA 11.1 View